These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18155349)

  • 1. Disulfiram-like effect of cyproterone acetate.
    Nitzan Z; Dan M
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):236. PubMed ID: 18155349
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on "Disulfiram-like effect of cyproterone acetate" [Z. Nitzan, M. Dan, Eur. J. Obstet. Gynecol. Reprod. Biol.].
    Karamanakos PN; Pappas P; Marselos M
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):237. PubMed ID: 18353525
    [No Abstract]   [Full Text] [Related]  

  • 3. Fomepizole for severe disulfiram-ethanol reactions.
    Sande M; Thompson D; Monte AA
    Am J Emerg Med; 2012 Jan; 30(1):262.e3-5. PubMed ID: 21208769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen--progestogen in HAIR-AN syndrome.
    Vaidya RA; Shringi MS; Vaidya AB; Gogate JG
    J Assoc Physicians India; 1997 Nov; 45(11):883-4. PubMed ID: 11229194
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pulmonary thromboembolism in primary care].
    Esteban-Jiménez O; Velázquez-Lupiáñez L; Martínez-Raposo Piedrafita MC; Cebollada-Gracia AD
    Semergen; 2013 Apr; 39(3):175-8. PubMed ID: 23540994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
    Spitzer WO
    J Obstet Gynaecol Can; 2004 Jun; 26(6):549-50. PubMed ID: 15762006
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A patient with a life-threatening disulfiram-ethanol reaction].
    Tummers-de Lind van Wijngaarden RF; Havenith T; Hurkens KP; de Vries F; Hulsewe-Evers HP
    Ned Tijdschr Geneeskd; 2013; 157(1):A5240. PubMed ID: 23298723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillophlebitis associated with the use of oral contraceptive: a case report.
    Eski Yücel O; Güngor I; Gül A; Turgut M; Aritürk N
    Gynecol Endocrinol; 2015; 31(8):601-3. PubMed ID: 26291803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD.
    Seaman HE; de Vries CS; Farmer RD
    Pharmacoepidemiol Drug Saf; 2003; 12(7):541-50. PubMed ID: 14558177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
    Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
    Pini M
    J Obstet Gynaecol Can; 2004 Jul; 26(7):625; author reply 626. PubMed ID: 15329967
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of Budd-Chiari syndrome induced by ethinylestradiol and cyproterone acetate].
    He JC; Xu P; Peng LB
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):954. PubMed ID: 20038345
    [No Abstract]   [Full Text] [Related]  

  • 14. Diane-35 (cyproterone acetate): safety concerns.
    Wooltorton E
    CMAJ; 2003 Feb; 168(4):455-6. PubMed ID: 12591790
    [No Abstract]   [Full Text] [Related]  

  • 15. Skin ulcers in a young woman on low-dose estrogen-combination pill.
    Siregusa M; Alberti A; Schepis C
    Int J Dermatol; 1997 Apr; 36(4):317-8. PubMed ID: 9169341
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
    Meltzer A
    J Obstet Gynaecol Can; 2004 May; 26(5):457-8. PubMed ID: 15224669
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth of a meningioma in a transsexual patient after estrogen-progestin therapy.
    Gazzeri R; Galarza M; Gazzeri G
    N Engl J Med; 2007 Dec; 357(23):2411-2. PubMed ID: 18057351
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acne: long-term therapy with side effect. Sebaceous gland activity is androgen dependent--acne therapeutic drug is effective as a contraceptive].
    Mehrl J
    Fortschr Med; 1988 Aug; 106(25):50-1. PubMed ID: 2971600
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescribing pitfalls: cyproterone acetate with ethinyloestradiol.
    Nicholls J
    Community Nurse; 2000 Jul; 6(6):45. PubMed ID: 12778650
    [No Abstract]   [Full Text] [Related]  

  • 20. First-use risks.
    Rowe TC
    CMAJ; 2003 May; 168(11):1394. PubMed ID: 12771065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.